Search
for

    Sort by

    Research 121–150 of 1000+

    1. Anabolic androgenic steroids and carcinogenicity focusing on Leydig cell: a literature review Oncotarget · 2018 · 65 citations
    2. Clinical biochemistry of dihydrotestosterone Annals of Clinical Biochemistry · 2013 · 50 citations
    3. The Double Edge Sword of Testosterone’s Role in the COVID-19 Pandemic Frontiers in Endocrinology · 2021 · 29 citations
    4. Testosterone Prevents Cutaneous Ischemia and Necrosis in Males Through Complementary Estrogenic and Androgenic Actions Arteriosclerosis, thrombosis, and vascular biology · 2017 · 12 citations
    5. Mechanism of action of bolandiol (19-nortestosterone-3β,17β-diol), a unique anabolic steroid with androgenic, estrogenic, and progestational activities 2009 · 11 citations
    6. Effects of non-contingent cocaine on 3alpha-androstanediol. I. Disruption of male sexual behavior Physiology & Behavior · 2019 · 4 citations
    7. Recent advances in the molecular mechanisms determining tissue sensitivity to glucocorticoids: novel mutations, circadian rhythm and ligand-induced repression of the human glucocorticoid receptor BMC Endocrine Disorders · 2014 · 62 citations
    8. Endocrine Functions of the Testes IntechOpen eBooks · 2021 · 3 citations
    9. Impact of estrogens in males and androgens in females 2019 · 120 citations
    10. Developmental origin of polycystic ovary syndrome - a hypothesis Journal of Endocrinology · 2002 · 430 citations
    11. Neuroendocrinology of the hair follicle: principles and clinical perspectives Trends in Molecular Medicine · 2014 · 98 citations
    12. 12 Treatment of hirsutism with 5α-reductase inhibitors Clinics in endocrinology and metabolism · 1986 · 28 citations
    13. New approaches to the treatment of osteoporosis Current Opinion in Chemical Biology · 2000 · 28 citations
    14. New effects of caffeine on corticotropin‐releasing hormone (CRH)‐induced stress along the intrafollicular classical hypothalamic–pituitary–adrenal (HPA) axis (CRH‐R1/2, IP<sub>3</sub>‐R, ACTH, MC‐R2) and the neurogenic non‐HPA axis (substance P, p75<sup>NTR</sup>and TrkA) in<i>ex vivo</i>human male androgenetic scalp hair follicles British Journal of Dermatology · 2020 · 12 citations
    15. Physiopathology of polycystic ovary syndrome in endocrinology, metabolism and inflammation Journal of Ovarian Research · 2025 · 70 citations
    16. Recent approaches of antibody therapeutics in androgenetic alopecia Frontiers in Pharmacology · 2024
    17. The human skin as a hormone target and an endocrine gland Hormones · 2004 · 146 citations
    18. AROMA THERAPY: AN ART OF HEALING Indian Research Journal of Pharmacy and Science · 2018 · 15 citations
    19. Metastatic Embryonal Cell Carcinoma with High Testosterone and Absence of Secondary Sexual Characteristics AACE Clinical Case Reports · 2016
    20. Synthesis and Actions of 5α-Reduced Metabolites of Testosterone in the Nervous System Androgens · 2021 · 1 citations
    21. Glucocorticoid Receptor Mutants Demonstrate Increased Motility Inside the Nucleus of Living Cells: Time of Fluorescence Recovery After Photobleaching (FRAP) Is an Integrated Measure of Receptor Function Molecular Medicine · 2004 · 31 citations
    22. Primary Generalized Glucocorticoid Resistance or Chrousos Syndrome: Allostasis Through a Mutated Glucocorticoid Receptor Springer eBooks · 2016
    23. The mineralocorticoid receptor as a novel player in skin biology: beyond the renal horizon? Experimental Dermatology · 2009 · 40 citations
    24. What is the Rationale for Androgen Therapy for Women? Treatments in Endocrinology · 2003 · 20 citations
    25. Local synthesis and function of neuro-estrogen and neuro-androgen: impact on the hippocampus-related cognition and neuronal plasticity Frontiers in Cellular Neuroscience · 2026
    26. Androgen Treatment in Women Postgraduate obstetrics & gynecology · 2007
    27. Androgen treatment in women Current Opinion in Endocrinology & Diabetes · 2006
    28. Prevalence of CYP21 mutations and IRS1 variant among women with polycystic ovary syndrome and adrenal androgen excess Fertility and Sterility · 2005 · 40 citations
    29. Vitamin D receptor polymorphisms and the polycystic ovary syndrome: A systematic review Journal of Obstetrics and Gynaecology Research · 2017 · 36 citations
    30. Evaluation of the role of soluble receptors for advanced glycosylated end-products in polycystic ovarian syndrome Evidence Based Women Health Journal (Online) · 2016